A diabetes diagnosis can be life-changing. We explore the impact of finding out you have diabetes - from the initial shock to dealing with your emotions and everything in between. Diabetes doesn't ...

There are some very early clues to suggest that coronavirus might be triggering type 1 or type 2 diabetes in some people, or making the condition worse for others. We take a look at the evidence and ...

Our new analysis predicts that, without significant government action, up to 5.5m people in the UK could be living with diabetes by 2030.

Devastating diabetes complications costs the UK healthcare system £6.2 billion a year, which highlights not just the seriousness of diabetes but also the importance of getting the right care to people ...

Everything you need to know about type 2 diabetes remission. Find out what type 2 diabetes remission is, how it works, and what the benefits are.

UPDATE, 22 MAY 2024: We now have new information on the amount of people living with the diabetes, and for more information you can visit our guide on diabetes statistics. The number of people living ...

Causes of type 1 diabetes It’s normal to wonder if something you’ve done could have caused your type 1 diabetes – or a child’s type 1 diabetes. But there’s nothing you could have done to prevent it.

We're going to explore whether an intermittent fasting diet can help you put your type 2 diabetes into remission. What are intermitten ...

We explain what causes gestational diabetes, what the most common risk factors are and how you can take steps to reduce your risk.

Update, 14 August 2025: The Medicines and Healthcare products Regulatory Agency (MHRA) has licensed teplizumab as the first-ever immunotherapy for type 1 diabetes in the UK. Read our news story to ...

Our new data shows that an urgent intervention is needed in diabetes care and type 2 diabetes prevention to lower the number of people living with diabetes or prediabetes. Save for later Page saved!

The first ever immunotherapy for type 1 diabetes has been licensed for use in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) has decided teplizumab, also known as Tzield, is ...